Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Caplin Point Labs
Add new alert
CAPLIPOINT •
NSE
Caplin Point Laboratories
₹1,662.20
-25.40 (1.51%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
Livesquawk •
16 hours ago
Caplin Point Labs secures USFDA approval for Potassium Phosphates Injection via subsidiary Caplin Steriles Limited. The product's US sales are projected at $57M in 2026.
ScoutQuest •
2 weeks ago
Caplin Point subsidiary Caplin Steriles gets USFDA nod for Desmopressin Acetate Injection ANDA. Approved vials treat haemophilia A, von Willebrand disease, diabetes insipidus; US sales hit $26M in 2025.
Livesquawk •
3 weeks ago
Caplin Point Lab gets U.S. FDA nod for Sodium Phosphates Injection. The product is projected to achieve $67M in U.S. sales by 2025.
Marketsmojo •
1 month ago
Caplin Point Laboratories achieved record net sales and profitability for Dec 2025 quarter. Operational efficiency and return ratios faced pressure, reflecting a flat financial trend.
BSE •
1 month ago
Caplin Point Laboratories shared Q3 FY25-26 earnings call audio on their website. The call, held on Feb 5, 2026, was announced under Regulation 30 (LODR).
Livesquawk •
1 month ago
Caplin Point Labs reported Q3 revenue of 5.4B INR, up from 5B YoY.
BSE •
1 month ago
Caplin Point Laboratories shareholders approved new director appointments on Jan 31, 2026. Mrs. Susan Mathew joins as Independent Director for a 5-year term from Jan 31, 2026.
ScoutQuest •
2 months ago
Caplin Steriles, part of Caplin Point Labs, received USFDA approval for Methylprednisolone Acetate. The drug, a generic of Pfizer's DEPO MEDROL, targets a $57.4M US market by Nov 2025.
The Hindu BusinessLine •
2 months ago
Caplin Point Labs, via subsidiaries CSL and COL, acquired 10 approved ANDAs for injectables and ophthalmics. The acquisition is from a leading multinational generic product manufacturer, boosting Caplin's US presence.
ScoutQuest •
2 months ago
Caplin Point acquires 10 approved ANDAs targeting US market worth $473.2M by Aug 2025. Oncology injectables to be commercialized; plans expansion to Mexico, Canada, EU, Brazil.